Gray, CA
Alane M. Gray, Brisbane, CA US
Patent application number | Description | Published |
---|---|---|
20110142859 | ANTIBODIES AND IMMUNOCONJUGATES AND USES THEREFOR - Anti-CD22 antibodies and immunoconjugates thereof are provided. Methods of using anti-CD22 antibodies and immunoconjugates thereof are provided. | 06-16-2011 |
20120329094 | Anti-CD22 Antibodies And Immunoconjugates and Methods of Use - Anti-CD22 antibodies and immunoconjugates thereof are provided. Methods of using anti-CD22 antibodies and immunoconjugates thereof are provided. | 12-27-2012 |
20130171170 | ANTIBODIES AND IMMUNOCONJUGATES AND USES THEREFOR - Anti-CD22 antibodies and immunoconjugates thereof are provided. Methods of using anti-CD22 antibodies and immunoconjugates thereof are provided. | 07-04-2013 |
20140127197 | Anti-CD22 Antibodies and Immunoconjugates and Methods of Use - Anti-CD22 antibodies and immunoconjugates thereof are provided. Methods of using anti-CD22 antibodies and immunoconjugates thereof are provided. | 05-08-2014 |
Alan S. Gray, San Jose, CA US
Patent application number | Description | Published |
---|---|---|
20110122130 | Modifying Perspective of Stereoscopic Images Based on Changes in User Viewpoint - Modifying perspective of stereoscopic images provided by one or more displays based on changes in user viewpoint. The one or more displays may include a first display that is provided substantially horizontal for displaying 3D horizontal perspective images and/or a second display that is provided substantially vertical for displaying text or conventional images such as 2D images, or 3D vertical perspective images. The horizontal display surface may be typically positioned directly in front of the user, and at a height of about a desktop surface so that the user can have about a 45° looking angle. The vertical display surface may be positioned in front of the user and preferably behind and above the horizontal display surface. | 05-26-2011 |
20110187706 | Presenting a View within a Three Dimensional Scene - Presenting a view based on a virtual viewpoint in a three dimensional (3D) scene. The 3D scene may be presented by at least one display, which includes displaying at least one stereoscopic image of the 3D scene by the display(s). The 3D scene may be presented according to a first viewpoint. A virtual viewpoint may be determined within the 3D scene that is different than the first viewpoint. The view of the 3D scene may be presented on the display(s) according to the virtual viewpoint and/or the first view point. The presentation of the view of the 3D scene is performed concurrently with presenting the 3D scene. | 08-04-2011 |
20140240312 | Presenting a View within a Three Dimensional Scene - Presenting a view based on a virtual viewpoint in a three dimensional (3D) scene. The 3D scene may be presented by at least one display, which includes displaying at least one stereoscopic image of the 3D scene by the display(s). The 3D scene may be presented according to a first viewpoint. A virtual viewpoint may be determined within the 3D scene that is different than the first viewpoint. The view of the 3D scene may be presented on the display(s) according to the virtual viewpoint and/or the first view point. The presentation of the view of the 3D scene is performed concurrently with presenting the 3D scene. | 08-28-2014 |
20140313190 | Modifying Perspective of Stereoscopic Images Based on Changes in User Viewpoint - Modifying perspective of stereoscopic images provided by one or more displays based on changes in user viewpoint. The one or more displays may include a first display that is provided substantially horizontal for displaying 3D horizontal perspective images and/or a second display that is provided substantially vertical for displaying text or conventional images such as 2D images, or 3D vertical perspective images. The horizontal display surface may be typically positioned directly in front of the user, and at a height of about a desktop surface so that the user can have about a 45° looking angle. The vertical display surface may be positioned in front of the user and preferably behind and above the horizontal display surface. | 10-23-2014 |
Allan David Ross Gray, Menlo Park, CA US
Patent application number | Description | Published |
---|---|---|
20090259522 | SYSTEM AND METHODS FOR GENERATING QUANTITATIVE PRICING POWER AND RISK SCORES - The present invention relates to a quantitative pricing power and pricing risk score generator and methods therefore, useful in association with an integrated price management system. Such a system may include a segment generator, a segment pricing power analyzer, and a segment pricing risk analyzer. The segment generator may receive or generate segments associated with a customer. Segment generation uses transaction level data which includes product attribute information, market data, and transaction history data. The segment pricing power analyzer and risk analyzer identify pricing power and risk factors, and assign raw scores to each factor, generates a weight for each raw score for each of the pricing power factors, and generates the quantitative pricing power and risk scores for each segment by computing a weighted average of the factors using the generated weights for each of the raw scores. Weights may be assigned according to default values or may be generated via an optimization. | 10-15-2009 |
20090259523 | SYSTEM AND METHODS FOR CALIBRATING PRICING POWER AND RISK SCORES - The present invention relates to a power and risk score calibrator which includes segment pricing power and risk reconcilers, a segment cartographer, segment power and risk aggregators, pricing power and risk value comparers, and pricing power and risk value calibrators. The reconcilers receive quantitative power and risk scores for each quantitative segment, and receive qualitative power and risk scores for each qualitative segment. The qualitative segment and the qualitative power and risk scores are defined by a user. The cartographer generates consolidated segments. The aggregators may then generate consolidated power and risk scores for each of the consolidated segments, respectively. The comparers then reconcile gaps between the qualitative power and risk scores and the consolidated power and risk scores. From these reconciliations adjustment factors are generated, which are applied by pricing power and risk value calibrators. The calibrators may also perform a drill down to explain the gap between the qualitative scores and the consolidated scores. | 10-15-2009 |
Andrew P. Gray, San Marcos, CA US
Patent application number | Description | Published |
---|---|---|
20090092509 | Apparatus and method for magnetic-based manipulation of microscopic particles - Apparatus and method for manipulating particles on a micro- or nano-scale. An embodiment of the present invention includes a magnetic micro-manipulation technique that utilizes micro-coils and soft magnetic microscopic wires for localized manipulation of particles. Another embodiment of the present invention uses magneto-static interaction between two magnetic microscopic wires to mechanically manipulate particles. Yet another embodiment of the present invention combines a magnetic particle with a magnetic manipulator or other device for generating magnetic fields to operate as a micro-fluidic micro-motor. Other embodiments of the present invention employ a magnetic separation system employing porous membranes partially filled with magnetic wires. | 04-09-2009 |
Barry Charles Gray, Menlo Park, CA US
Patent application number | Description | Published |
---|---|---|
20090087181 | IN-WALL OPTICAL NETWORK UNIT - One embodiment provides an ONU that includes an optical interface coupled to an optical transceiver, which is configured to transmit optical signals to and receive optical signals from an OLT through the optical interface. The ONU also includes an ONU chip coupled to the optical transceiver and configured to communicate with the OLT through the optical transceiver. The ONU further includes an Ethernet interface coupled to the ONU chip and a power management module configured to provide power to the ONU chip and the optical transceiver using power delivered from a CPE through the Ethernet interface. In addition, the ONU includes a circuit board to which the optical transceiver, the ONU chip, and the power management module are attached, and a wall-mountable fixture, wherein the front side of the fixture includes an opening for the Ethernet interface, and wherein the back side of the fixture holds the circuit board. | 04-02-2009 |
Bill Gray, San Francisco, CA US
Patent application number | Description | Published |
---|---|---|
20100237629 | Flywheel system - A flywheel system has an approximately toroidal flywheel rotor having an outer radius, the flywheel rotor positioned around and bound to a hub by stringers, the stringers each of a radius slightly smaller than the outer radius of the flywheel rotor. The hub is suspended from a motor-generator by a flexible shaft or rigid shaft with flexible joint, the flywheel rotor having a mass, substantially all of the mass of the flywheel rotor comprising fibers, the fibers in large part movable relative to each other. The motor-generator is suspended from a damped gimbal, and the flywheel rotor and motor-generator are within a chamber evacuatable to vacuum. An electrostatic motor/generator can also be within the same vacuum as the flywheel. | 09-23-2010 |
20110175371 | Flywheel system - A flywheel system has an approximately toroidal flywheel rotor having an outer radius, the flywheel rotor positioned around and bound to a hub by stringers, the stringers each of a radius slightly smaller than the outer radius of the flywheel rotor. The hub is suspended from a motor-generator by a flexible shaft or rigid shaft with flexible joint, the flywheel rotor having a mass, substantially all of the mass of the flywheel rotor comprising fibers, the fibers in large part movable relative to each other. The motor-generator is suspended from a damped gimbal, and the flywheel rotor and motor-generator are within a chamber evacuatable to vacuum. An electrostatic motor/generator can also be within the same vacuum as the flywheel. | 07-21-2011 |
20120096984 | Flywheel System - A flywheel system has damped gimbal system suspending a motor generator which is in turn linked by means of any number of flexible couplings and rigid shafts to a flywheel rotor system so as to provide safe passive stability to the highly energized spinning rotor system and high torque transmitting capacity. | 04-26-2012 |
20130134810 | Flywheel system - A flywheel system has an approximately toroidal flywheel rotor having an outer radius, the flywheel rotor positioned around and bound to a hub by stringers, the stringers each of a radius slightly smaller than the outer radius of the flywheel rotor. The hub is suspended from a motor-generator by a flexible shaft or rigid shaft with flexible joint, the flywheel rotor having a mass, substantially all of the mass of the flywheel rotor comprising fibers, the fibers in large part movable relative to each other. The motor-generator is suspended from a damped gimbal, and the flywheel rotor and motor-generator are within a chamber evacuatable to vacuum. An electrostatic motor/generator can also be within the same vacuum as the flywheel. | 05-30-2013 |
Brian C. Gray, Lake Forest, CA US
Patent application number | Description | Published |
---|---|---|
20110218622 | INDUCTION ACTIVATION OF ADJUSTABLE ANNULOPLASTY RINGS AND OTHER IMPLANTABLE DEVICES - Systems and methods to adjust an adjustable medical device that is implanted subcutaneously within the body of a patient. The adjustable medical device is coupled to an adjustment mechanism configured to, when powered, effect a desired adjustment to the adjustable medical device. The adjustment mechanism is electrically coupled to a receiving coil configured to resonate at a desired frequency such that an electric current induced in the receiving coil powers the adjustment mechanism. An induction activation system is configured to utilize magnetic resonance to wirelessly activate the adjustable medical device assembly, from outside the patient's body, through a skin barrier of the patient. The induction activation system comprises a power source and a delivery coil. The power source creates an alternating electrical signal. The delivery coil is electrically coupled to the power source and configured to resonate in response to the alternating electrical signal created by the power source, and thereby generate a resonating magnetic field. The delivery coil is tuned to have a resonant frequency that is the same as a frequency of the alternating electrical signal created by the power source. The receiving coil can also be tuned to resonate at the resonant frequency of the delivery coil. When the delivery coil is positioned near the patient's body, such that the receiving coil is within the magnetic field generated by the delivery coil, an electric current is induced in the receiving coil to drive the adjustment mechanism and thereby effect an adjustment of the adjustable medical device. | 09-08-2011 |
20120123531 | PERCUTANEOUS TRANSCATHETER REPAIR OF HEART VALVES - Apparatus, systems, and methods are provided for repairing heart valves through percutaneous transcatheter delivery and fixation of annuloplasty rings to heart valves. An annuloplasty ring includes an outer hollow member including a plurality of segments. Adjacent segments cooperate with one another to change the outer hollow member from an elongate insertion geometry to an annular operable geometry. The annuloplasty ring also includes an internal anchor member located at least partially within the outer hollow member. The internal anchor member includes a plurality of anchors configured to attach the annuloplasty ring to tissue of a heart valve annulus. The internal anchor member is configured to move the plurality of anchors with respect to a plurality of windows in the outer hollow member to selectively deploy the plurality of anchors through the respective windows. | 05-17-2012 |
20120197392 | ADJUSTABLE ANNULOPLASTY RING WITH SUBCUTANEOUS ACTIVATION PORT - Annuloplasty rings are employed to treat heart valve defects, such as regurgitation. Synching the heart tissue to the ring restores the valve opening to its approximate original size and operating efficiency. Adjustable annuloplasty rings allow for a proper degree of synching both during open heart surgery and over the patient's lifetime. A subcutaneous port may be coupled to an adjustable annuloplasty ring such that an external activation energy generator can be used to heat the adjustable annuloplasty ring and thereby adjust the size of the annuloplasty ring. | 08-02-2012 |
20130289718 | PERCUTANEOUS TRANSCATHETER REPAIR OF HEART VALVES - Apparatus, systems, and methods are provided for repairing heart valves through percutaneous transcatheter delivery and fixation of annuloplasty rings to heart valves. An annuloplasty ring includes an outer hollow member including a plurality of segments. Adjacent segments cooperate with one another to change the outer hollow member from an elongate insertion geometry to an annular operable geometry. The annuloplasty ring also includes an internal anchor member located at least partially within the outer hollow member. The internal anchor member includes a plurality of anchors configured to attach the annuloplasty ring to tissue of a heart valve annulus. The internal anchor member is configured to move the plurality of anchors with respect to a plurality of windows in the outer hollow member to selectively deploy the plurality of anchors through the respective windows. | 10-31-2013 |
Cameron Gray, Half Moon Bay, CA US
Patent application number | Description | Published |
---|---|---|
20110320333 | SYSTEM AND METHODS FOR VALUING AND TRADING INTANGIBLE PROPERTIES AND INSTRUMENTS - A system and methods providing an exchange network for valuing and trading of intangible instruments, such as one or more rights to an intangible property including a given intellectual property (patents, copyrights, trademarks, trade dress, trade secrets and/or the rights of publicity). The system and methods permits a party to access a database of the intangible instruments including data relating to identifying value of the instrument. The system and methods permits a party to perform due diligence on the intangible instrument and, as a result, to formulate a bidding strategy for the intangible instrument that the bidder believes is appropriate. If the bidder and the owner reach agreement on the price, a transaction for the intangible instrument is executed between the parties. | 12-29-2011 |
Caroline Gray, Foothill Ranch, CA US
Patent application number | Description | Published |
---|---|---|
20110279034 | LIGHT FIXTURE WITH FLAMELESS CANDLE - Light fixtures are disclosed having a first light source. The light fixtures can include a second light source, and a flameless candle that includes the first light source. A sensor can also be included that is configured to detect at least one of movement and light, and produces a sensor signal. | 11-17-2011 |
Chad Gray, Redwood City, CA US
Patent application number | Description | Published |
---|---|---|
20100318408 | METHOD AND SYSTEM FOR GENERATING QUANTITATIVE INDICATORS - A method of generating a quantitative indicator of sales for a market segment for a predetermined time period is disclosed. The market segment represents a plurality of members with one or more products. The method includes receiving sales data from the plurality of members of the market segment, calculating the quantitative indicator for each member of the market segment, calculating the quantitative indicator for the market segment by creating a composite of the quantitative indicator for each member representing the market segment, and either calculating the quantitative indicator for the member with missing data using a estimated value of units of the product sold by the member or modifying the baseline benchmark by removing the data of the member with missing data. | 12-16-2010 |
Daniel C. Gray, San Francisco, CA US
Patent application number | Description | Published |
---|---|---|
20080220471 | Vectors and Methods Using Same - The present invention is directed to vectors and to methods of using same. | 09-11-2008 |
Daniel C. Gray, San Franciso, CA US
Patent application number | Description | Published |
---|---|---|
20100077495 | COMPOSITIONS AND METHODS FOR THE EXPRESSION OF NUCLEIC ACIDS - Compositions and methods are provided herein for the expression of nucleic acids. Compositions and methods are also provided herein for inducible expression of nucleic acids in transgenic cells and animals using transposon-based nucleic acid constructs. Compositions and methods are also provided herein for modulation of endogenous gene expression. | 03-25-2010 |
Darren Gray, La Jolla, CA US
Patent application number | Description | Published |
---|---|---|
20090071831 | Methods and systems for producing arrays of particles - The invention provides apparatus and methods for arraying particles on a surface using dielectrophoresis. | 03-19-2009 |
20110272282 | SYSTEMS AND METHODS FOR ENHANCED SCODA - Methods and apparatus for concentrating particles may be applied, for example, to concentrating DNA, RNA, proteins and the like. Proteins may be pre-treated to facilitate concentration by scodaphoresis. The pre-treatment may comprise, for example, heating or chemical treatment to denature and/or apply a net charge to the protein, binding handle particles to the protein and combinations thereof. High-conductivity samples may be subjected to a conductivity-reduction step to facilitate electrical injection of target particles into scodaphoresis media. The conductivity-reduction step may comprise a buffer exchange process or a salt extraction process, for example. Methods and apparatus can allow two or more different types of target particles to be extracted from the same sample and separately concentrated. These various aspects may be applied individually or in any combination. | 11-10-2011 |
David Gray, Windsor, CA US
Patent application number | Description | Published |
---|---|---|
20080255652 | Expandable Tip Delivery System and Method - A method of deploying a stent-graft in a curved vessel includes deploying an expandable tip to center a proximal end of the catheter containing a stent-graft in the curved vessel. A sheath is retracted to expose the stent-graft and the stent-graft self-expands into the curved vessel. By centering the catheter containing the stent-graft prior to deployment with the expandable tip, the accuracy of stent graft placement within the curved vessel is improved. | 10-16-2008 |
20090270971 | Prosthesis Fixation Apparatus and Methods - A tubular prosthesis comprises a tubular graft; and an undulating stent having a plurality of apexes, a first end defined at least in part by a first group of the apexes, and a second end defined at least in part by a second group of the apexes, the first group of apexes being pivotally attached to the tubular graft so as to form a plurality of circumferentially arranged hinges about which the stent can pivot so that the second group of apexes can move between a position where they are inside the tubular graft and a position where they are outside the tubular graft. In one embodiment a tubular prosthesis comprises a tubular graft having a first end margin, a second end margin and a central portion therebetween; and an undulating stent having a plurality of apexes, a first end defined at least in part by a first group of the apexes, and a second end defined at least in part by a second group of the apexes, the undulating stent being secured to the tubular graft in a manner such that it can be inverted to extend generally in the same direction as the tubular graft with one end thereof forming an end of said tubular prosthesis and pointing away from the central portion of the tubular graft. | 10-29-2009 |
Donald Gray, San Francisco, CA US
Patent application number | Description | Published |
---|---|---|
20100075327 | INTERMITTENT DETECTION DURING ANALYTICAL REACTIONS - Methods, devices, and systems for performing intermittent detection during analytical reactions are provided. Such methods facilitate collection of reaction data from disparate reaction times. Further, such methods are useful for reducing photo-induced damage of one or more reactants in an illuminated analytical reaction at a given reaction time. In preferred embodiments, the reaction mixture is subjected to at least one illuminated and non-illuminated period and allowed to proceed such that the time in which the reaction mixture is illuminated is less than a photo-induced damage threshold period. | 03-25-2010 |
Douglas R. Gray, Mountain View, CA US
Patent application number | Description | Published |
---|---|---|
20100309225 | IMAGE MATCHING FOR MOBILE AUGMENTED REALITY - Embodiments of a system and method for mobile augmented reality are provided. In certain embodiments, a first image is acquired at a device. Information corresponding to at least one second image matched with the first image is obtained from a server. A displayed image on the device is augmented with the obtained information. | 12-09-2010 |
Eric John Gray, Rohnert Park, CA US
Patent application number | Description | Published |
---|---|---|
20080277994 | Furniture protector device - Furniture protector device comprising: a plurality of side by side rigid elongate members forming an upper layer of rigid members and and a lower layer of rigid members. The layers are attached to each other by standard equally space pins to form a standard expandable lattice structure. A plurality of spike members are perpendicularly attached to the rigid members of the upper layer. A pair of handle members are each attached to rigid members located on the right and left side of the upper layer. The lattice structure can be expanded to cover the entire horizontal surface of a standard sofa or contracted for compact storage. | 11-13-2008 |
Eric John Gray, Sunnyvale, CA US
Patent application number | Description | Published |
---|---|---|
20090259502 | Quality-Based Media Management for Network-Based Media Distribution - Disclosed are techniques and configurations for monitoring quality of digital media assets available from a network-based media distribution system, and taking action to make those digital media assets that have quality deficiencies unavailable from the network-based media distribution system. The network-based media distribution system can provide an online media store from which users can acquire those of the digital media assets that are deemed available. In one embodiment, digital media assets that have quality deficiencies can be rapidly discovered and automatically removed from being available at an online media store. | 10-15-2009 |
20120023015 | Consolidated Payment and Bank Error Correction - Improved techniques are disclosed for payment of accrued moneys via a third party intermediary. In one embodiment, a consolidated royalty can be provided for online sales of digital assets of a digital asset provider. Since the online sales can be from various different countries, the online sales can be in a plurality of different currencies. The royalties due a digital asset provider from online sales in the different currencies can be consolidated at appropriate times into a single currency and then disbursed to the digital asset provider. In another embodiment, royalty disbursement management can be provided to alert a digital asset provider that an attempted distribution has failed and to facilitate the digital asset provider in correcting appropriate banking information to assist in obviating the distribution failure. | 01-26-2012 |
Frederick John Gray, Woodland Hills, CA US
Patent application number | Description | Published |
---|---|---|
20090118711 | REDUCED-NOISE IMPLANTABLE INFUSION DEVICE - A drive mechanism for delivery of infusion medium in an implantable medical device includes an inlet for receiving the infusion medium and a piston channel for communication of infusion medium received by the inlet. The piston channel has a distal end and a proximal end. The proximal end is closer to the inlet than the distal end. The drive mechanism further includes a coil surrounding the piston channel and a piston located within the piston channel and moveable axially within the piston channel to drive infusion medium out of the distal end of the piston channel. The mechanism also includes an armature operably coupled to the piston and disposed adjacent the coil. The armature has first and second opposing major surfaces and a plurality of vents extending through the armature from the first major surface to the second major surface. The plurality of vents cumulatively occupy between about 20% and about 40% of the total surface area of the first major surface. Electromagnetic interaction between the armature and the coil cause the piston move in the channel. | 05-07-2009 |
Gary Gray, Stanford, CA US
Patent application number | Description | Published |
---|---|---|
20080213245 | ENZYME TREATMENT OF FOODSTUFFS FOR CELIAC SPRUE - Administering an effective dose of glutenase to a Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides, thereby attenuating or eliminating the damaging effects of gluten. | 09-04-2008 |
20080213427 | ENZYME TREATMENT OF FOODSTUFFS FOR CELIAC SPRUE - Administering an effective dose of glutenase to a Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides, thereby attenuating or eliminating the damaging effects of gluten. | 09-04-2008 |
20080213822 | METHODS FOR DIAGNOSING CELIAC SPRUE AND REAGENTS USEFUL THEREIN - Administering an effective dose of glutenase to a Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides, thereby attenuating or eliminating the damaging effects of gluten. | 09-04-2008 |
20090280555 | ENZYME TREATMENT OF FOODSTUFFS FOR CELIAC SPRUE - Administering an effective dose of glutenase to a Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides, thereby attenuating or eliminating the damaging effects of gluten. | 11-12-2009 |
20110293724 | Enzyme Treatment of Foodstuffs for Celiac Sprue - Administering an effective dose of glutenase to a Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides, thereby attenuating or eliminating the damaging effects of gluten. | 12-01-2011 |
Gary M. Gray, Stanford, CA US
Patent application number | Description | Published |
---|---|---|
20120156253 | Enzyme Treatment of Foodstuffs for Celiac Sprue - Administering an effective dose of glutenase to a Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides, thereby attenuating or eliminating the damaging effects of gluten. | 06-21-2012 |
Gavin Gray, Sun Valley, CA US
Patent application number | Description | Published |
---|---|---|
20120295338 | MONITORING SYSTEMS FOR BIOMASS PROCESSING SYSTEMS - A sensor array is disclosed that includes a conduit having a lumen extending between an inlet and an outlet of the conduit. The sensor array can include a plurality of sensors coupled to the conduit. Each sensor can have a probe member that is disposed within the lumen. The sensors can be configured to measure at least one parameter of an aqueous medium containing a biomass. | 11-22-2012 |
Geoffrey Alan Gray, Santa Barbara, CA US
Patent application number | Description | Published |
---|---|---|
20100269371 | ORTHOTIC SHOE INSERT FOR HIGH-HEELED SHOES - An orthotic insert for a high-heeled shoe may have an asymmetrical heel cup including a depressed central region configured for a heel of a wearer. Features including an elevated medial-side surface along a medial side upper surface declining toward the central region, and a generally longitudinal lateral-side elevation along an upper lateral edge of the heel cup may be configured to provide a predetermined supported calcaneal angle for a wearer, wherein the angle is offset from vertical. An anterior retention structure configured as a rounded hump extending across an anterior region of the heel cup, generally transverse to the elevated medial-side surface, with a middle portion of the rounded hump curved laterally away from a center of the heel cup may be included to prevent anterior calcaneal movement relative to the heel cup. | 10-28-2010 |
George R. Gray, Fremont, CA US
Patent application number | Description | Published |
---|---|---|
20090139613 | HYPERELASTIC SHAPE SETTING DEVICES AND FABRICATION METHODS - Shape-setting methods for fabricating devices made of single crystal shape memory alloys. The method include drawing a single crystal of a shape memory alloy from a melt of the alloy. This is followed by heating and quenching the crystal sufficiently rapid to limit the formation of alloy precipitates to an amount which retains hyperelastic composition and properties of the crystal. | 06-04-2009 |
Gordon P. Gray, Menlo Park, CA US
Patent application number | Description | Published |
---|---|---|
20090082034 | WIRELESS CLIENT POSITION ESTIMATING SYSTEM AND METHOD - The present invention comprises a system and method for determining an estimated position of a wireless mobile client device operating in a communications environment covered by a wireless local area network. The received signal strength of the wireless mobile client device is measured by one or more access points serving devices in the communications environment. In a preferred embodiment, the error between the received signal strength measured by the access points and the expected received signal strength at a plurality of locations in the communications environment is calculated. The location of the device is determined from the error. | 03-26-2009 |
20140031062 | WIRELESS CLIENT POSITION ESTIMATING SYSTEM AND METHOD - The present invention comprises a system and method for determining an estimated position of a wireless mobile client device operating in a communications environment covered by a wireless local area network. The received signal strength of the wireless mobile client device is measured by one or more access points serving devices in the communications environment. In a preferred embodiment, the error between the received signal strength measured by the access points and the expected received signal strength at a plurality of locations in the communications environment is calculated. The location of the device is determined from the error. | 01-30-2014 |
Gordon Paul Gray, Menlo Park, CA US
Patent application number | Description | Published |
---|---|---|
20090028118 | METHODS, APPARATUSES AND SYSTEMS FACILITATING MANAGEMENT OF AIRSPACE IN WIRELESS COMPUTER NETWORK ENVIRONMENTS - Methods, apparatuses and systems facilitating the management of wireless computer network environments and the detection of rogue and other devices that may affect the performance and/or security of the wireless computer network. The present invention enables accurate and cost effective WLAN airspace mapping. In one embodiment, the present invention allows any conforming access point the ability to routinely scan its airspace, collect data on all operating frequencies and report this information back to a management platform. In one embodiment, the management and reporting functionality described herein uses a standards-based vehicle, such as Simple Network Management Protocol (SNMP). In one embodiment, the present invention facilitates isolation of rogue wireless devices affecting the computer network environment and effective decision-making as to management of the detected device. The present invention also allows network administrators to optimize the configuration of the wireless network environment for performance and security. | 01-29-2009 |
20140036841 | METHODS, APPARATUSES AND SYSTEMS FACILITATING MANAGEMENT OF AIRSPACE IN WIRELESS COMPUTER NETWORK ENVIRONMENTS - According to one embodiment, a particular network device that comprises at least one hardware processor is described. The network device is configured to perform operations including operating in a first mode by communicating wirelessly with at least one wireless client device to provide the at least one wireless client device access to one or more resources, where the operating in the first mode comprises receiving packets transmitted by the at least one wireless client device and forwarding the packets to the one or more resources. Furthermore, the network device performs operations, including switching from operating in the first mode to operating in a monitoring mode and operating in the monitoring mode by decoding data packets addressed to network devices other than the particular network device. | 02-06-2014 |
20140122674 | ZERO TOUCH PROVISIONING - According to one embodiment, a method comprises automatically uploading device information from a first network device in a first operating state to a second network device in response to an event, such as an initial power up. The second network device is part of the cloud, and thus, providing cloud-based services. Subsequent to the uploading of the device information, the first network device receives information controlling the operation of the first network device based on the device information. | 05-01-2014 |
20140123124 | CLOUD-BASED FIRMWARE DISTRIBUTION SERVICE - According to one embodiment of the invention, a method for altering stored firmware within a network device comprises receiving, by a first network device, information to download firmware. This information is provided from the first network device to at least a second network device, which is communicatively coupled to the first network device. The information enables the second network device to access a second version of firmware different than a first version of firmware installed on the second network device. | 05-01-2014 |
Harry B. Gray, Pasadena, CA US
Patent application number | Description | Published |
---|---|---|
20090253149 | Novel Chemistry Used in Biosensors - The invention relates to novel compositions and methods for the detection of analytes using the nuclear reorganization energy, λ, of an electron transfer process. | 10-08-2009 |
20100003710 | Electrochemical Assay for the Detection of Enzymes - The invention relates to novel compositions and methods for the detection of enzymes using the nuclear reorganization energy, λ, of an electron transfer process. | 01-07-2010 |
20100305335 | Metallocorroles - Metallocorrole complexes of third row transition metals may be used as therapeutic agents, catalysts, components of oxygen detectors, and components of light emitting diodes. In particular, metallocorrole complexes of third row transition metals may be used as improved photosenitizers in photodynamic therapy; as improved catalysts in aziridination, epoxidation, and water splitting reactions; as improved in vivo imaging agents; and as improved components in the emissive layer of OLEDs. Due to their strongly sigma-donating nature, corroles are able to stabilize third row transition metals in high oxidation states. Third row transition metals are significantly more electropositive than their first and second row counterparts and may therefore act as improved catalysts. In addition, the high spin-orbit coupling constants of third row transition metals may lead to easier singlet-triplet inter-system crossing in the excited state, which in turn may allow for long-wavelength phosphorescence that is desirable for many applications. | 12-02-2010 |
20120012472 | NOVEL CHEMISTRY USED IN BIOSENSORS - The invention relates to novel compositions of disubstituted bipyridyl osmium complexes useful for the synthesis of labeled proteins, nucleic acids, and for the modification of electrodes. | 01-19-2012 |
20120156709 | Electrochemical Assay for the Detection of Enzymes - The invention relates to novel compositions and methods for the detection of enzymes using the nuclear reorganization energy, λ, of an electron transfer process. | 06-21-2012 |
20120313073 | NICKEL-BASED ELECTROCATALYTIC PHOTOELECTRODES - A photoelectrode, methods of making and using, including systems for water-splitting are provided. The photoelectrode can be a semiconductive material having a photocatalyst such as nickel or nickel-molybdenum coated on the material. | 12-13-2012 |
20130178360 | NICKEL-BASED ELECTROCATALYTIC PHOTOELECTRODES - The disclosure provides methods and compositions comprising metal alloy powders. The disclosure also provides a photoelectrode, methods of making and using, including systems for water-splitting are provided. The photoelectrode can be a semiconductive material having a photocatalyst such as nickel or nickel-molybdenum coated on the material. | 07-11-2013 |
20140179918 | METALLOCORROLES - Metallocorrole complexes of third row transition metals (see Formula I below) may be used as therapeutic agents, catalysts, components of oxygen detectors, and components of light emitting diodes. In particular, metallocorrole complexes of third row transition metals may be used as improved photosenitizers in photodynamic therapy; as improved catalysts in aziridination, epoxidation, and water splitting reactions; as improved in vivo imaging agents; and as improved components in the emissive layer of OLEDs. Due to their strongly sigma-donating nature, corroles are able to stabilize third row transition metals in high oxidation states. Third row transition metals are significantly more electropositive than their first and second row counterparts and may therefore act as improved catalysts. In addition, the high spin-orbit coupling constants of third row transition metals may lead to easier singlet-triplet inter-system crossing in the excited state, which in turn may allow for long-wavelength phosphorescence that is desirable for many applications. | 06-26-2014 |
20140311922 | NOVEL CHEMISTRY USED IN BIOSENSORS - The invention relates to novel compositions and methods for the detection of analytes using the nuclear reorganization energy, λ, of an electron transfer process. | 10-23-2014 |
20140342383 | ELECTROCHEMICAL ASSAY FOR THE DETECTION OF ENZYMES - The invention relates to novel compositions and methods for the detection of enzymes using the nuclear reorganization energy, λ, of an electron transfer process. | 11-20-2014 |
Heather Cornwell Gray, Oakland, CA US
Patent application number | Description | Published |
---|---|---|
20120245992 | Incentive Program Awarding Points Per-Mile-Driven - Embodiments in accordance with the present invention relate to incentive programs awarding loyalty points based at least in part upon the number of miles driven in a motor vehicle. Reward points may be earned by having the vehicle serviced at authorized locations. At the time of servicing, the authorized location notes a current vehicle odometer reading, and the odometer reading is communicated to an administrator of the loyalty program. The odometer reading is used to calculate a number of miles driven since the last authorized servicing, and the number of mile driven is then converted into loyalty points to be credited to a consumer of the vehicle. Thus, incentives for servicing only at authorized locations are provided to the consumer. | 09-27-2012 |
Howard R. Gray, Sebastopol, CA US
Patent application number | Description | Published |
---|---|---|
20120019134 | HIGH GAIN COATINGS AND METHODS - A halogen incandescent burner comprising a quartz body comprising a light emitting chamber, a filament positioned within the light emitting chamber, and a multilayer optical coating on at least a portion of the chamber. The coating may include a plurality of layers of a low refractive index material and a high refractive index material having a total thickness of at least nine microns, wherein the gain of the burner is at least 1.7. The high refractive index material may comprise tantala and the low refractive index material may comprise silica. | 01-26-2012 |
20120019135 | IR COATINGS AND METHODS - A lamp burner having a quartz body comprising a light emitting chamber intermediate a pair of end portions. A filament may be positioned within the light emitting chamber and a multilayer optical coating provided on at least a portion of the body. The coating may comprise a plurality of layers of a first material comprising silica, a plurality of layers of a second material comprising rutile titanium dioxide, and a plurality of layers of a third material having an index of refraction intermediate the indices of refraction of the layers of first material and the layers of second material. | 01-26-2012 |
Howard Robert Gray, Sebastopol, CA US
Patent application number | Description | Published |
---|---|---|
20090145745 | Thin film coating system and method - A method and system for depositing a thin film on a substrate. In the system a target material is deposited and reacted on a substrate surface to form a substantially non-absorbing thin film. The volume of non-absorbing thin film formed per unit of time may be increased by increasing the area of the surface by a factor of “x” and increasing the rate of deposition of the target material by a factor greater than the inverse of the factor “x” to thereby increase the rate of formation of the volume of non-absorbing thin film per unit of time. | 06-11-2009 |
H. Robert Gray, Sebastopol, CA US
Patent application number | Description | Published |
---|---|---|
20080305267 | Method and apparatus for low cost high rate deposition tooling - An apparatus and method for depositing material on an array of substrates. The array of substrates may be moved past one or more sources of deposition material in a first rotational motion. The array of substrates may also be concurrently moved in a second rotational motion. The combination of the first and second rotational motions cause each of the substrates to move about its longitudinal axis without gears and bearings. | 12-11-2008 |
J. Dixon Gray, Sherman Oaks, CA US
Patent application number | Description | Published |
---|---|---|
20090257988 | METHODS AND COMPOSITIONS FOR ACCELERATING THE GENERATION OF REGULATORY T CELLS EX VIVO - The present invention is directed to generating regulatory T cells by treating a cell culture that includes non-regulatory T cells with a regulatory composition. The invention encompasses methods utilizing a regulatory composition that includes agents that prevent methylation of the locus for the FOXP3 transcription factor, agents that accelerate differentiation of T cells into suppressor cells, and agents that are histone deacetylase inhibitors. The invention also encompasses compositions of regulatory T cells generated by culturing non-regulatory T cells with a regulatory composition as well as the use of such regulatory T cells in the treatment of autoimmune diseases and aberrant immune responses. | 10-15-2009 |
Jeff Gray, Sacramento, CA US
Patent application number | Description | Published |
---|---|---|
20100142410 | SYSTEM AND METHOD FOR PROVIDING VIRTUAL PRIVATE NETWORKS - A computerized system and method for automatically determining customized configurations for each of a plurality of endpoints of a virtual private network (VPN) and deploying the configurations to the endpoints, comprising: accepting, using an interface, parameters required for building the configurations from a user, the configurations enabling the endpoints to process a mixture of time sensitive and non-time sensitive data, and the parameters comprising: endpoint IP addressing scheme information and network design information; automatically generating, using at least one configuration engine, complete customized endpoint configurations for the parameters, and instantiating the configurations based on endpoint hardware-specific information, with no further input required from the user; and deploying, using a scheduler, the configurations to the endpoints of the at least one VPN, wherein the VPN is an mGRE VPN using NHRP protocol. | 06-10-2010 |
Jeff Gray, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20110305049 | PHASE-CONTROLLED UNINTERRUPTIBLE POWER SUPPLY - A phase-controlled power supply is disclosed. The power supply includes a power conditioner with an input configured to connect to an external source of electrical power, the power conditioner being configured to provide conditioned power on its output. The power supply also includes a transformer having a primary winding and a secondary winding, and a switching module coupled between the output of the power conditioner and to the primary winding of the transformer. The switching module has two modes of operation and a control signal input configured to accept a first control signal. The switching module includes a switching element configured to connect the power conditioner output to the primary winding of the transformer. The switching module operates in the first mode when the first control signal is in a first state, switching the first switching element at a first frequency and first duty cycle. The switching module operates in the second mode when the first control signal is in a second state, switching the first switching element at a frequency and duty cycle according to the first control signal. | 12-15-2011 |
Jeff Gray, Solano Beach, CA US
Patent application number | Description | Published |
---|---|---|
20080214411 | Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries - The present invention generally relates to methods and compositions for expressing proteins or polypeptides in prokaryotic hosts using eukaryotic signal sequences. | 09-04-2008 |
20100009857 | Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries - The present invention generally relates to methods and compositions for expressing proteins or polypeptides in prokaryotic hosts using eukaryotic signal sequences. | 01-14-2010 |
20110224102 | Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries - The present invention generally relates to methods and compositions for expressing proteins or polypeptides in prokaryotic hosts using eukaryotic signal sequences. | 09-15-2011 |
Jeff Gray, Solana Beach, CA US
Patent application number | Description | Published |
---|---|---|
20110174062 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE - The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using assays that detect one or more markers selected from the group consisting of cytochrome c and insulin-like growth factor IA as diagnostic and prognostic biomarkers in renal injuries. | 07-21-2011 |
20110195429 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE - The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using assays that detect one or more markers selected from the group consisting of soluble p-selectin, protein NOV homolog, soluble epidermal growth factor receptor, netrin-4, haptoglobin, heat shock protein beta-1, alpha-1-antitrypsin, leukocyte elastase, soluble tumor necrosis factor receptor superfamily member 6, soluble tumor necrosis factor ligand superfamily member 6, soluble intercellular adhesion molecule 2, active caspase-3, and soluble platelet endothelial cell adhesion molecule as diagnostic and prognostic biomarkers in renal injuries. | 08-11-2011 |
20110201038 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE - The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using assays that detect one or more markers selected from the group consisting of Cytoplasmic aspartate aminotransferase, soluble Tumor necrosis factor receptor superfamily member 5, soluble CD40 Ligand, soluble C-X-C Motif chemokine 16, S100-A12, Eotaxin, soluble E-selectin, Fibronectin, Granulocyte colony-stimulating factor, Granulocyte-macrophage colony-stimulating factor, Heparin-binding growth factor 2, soluble Hepatocyte growth factor receptor, Interleukin-1 receptor antagonist, Interleukin-1 beta, Interleukin-10, Interleukin-15, Interleukin-3, Myeloperoxidase, Nidogen-1, soluble Oxidized low-density lipoprotein receptor 1, Pappalysin-1, soluble P-selectin glycoprotein ligand 1, Antileukoproteinase, soluble Kit ligand, Tissue inhibitor of metalloproteinase 1, Tissue inhibitor of metalloproteinase 2, soluble Tumor necrosis factor, soluble Vascular cell adhesion molecule 1, and Vascular endothelial growth factor A as diagnostic and prognostic biomarkers in renal injuries. | 08-18-2011 |
20110207161 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE - The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using assays that detect one or more markers selected from the group consisting of soluble CD44 antigen, Angiopoietin-1, soluble Angiopoietin-1 receptor, C—X—C chemokine motif 5, soluble Endoglin, soluble Tumor-associated calcium signal transducer 1, Erythropoietin, soluble Fractalkine, Heme oxygenase 1, soluble Interleukin-1 receptor type II, soluble Interleukin-6 receptor subunit-alpha, Lymphotactin, Lymphotoxin-alpha, Stromelysin-1, C—C motif chemokine 22, C—C motif chemokine 5, and Thrombospondin-1 as diagnostic and prognostic biomarkers in renal injuries. | 08-25-2011 |
20110229915 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE - The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using assays that detect one or more markers selected from the group consisting of Epidermal growth factor, Complement C3, Interleukin-4, Interleukin-1 alpha, Tubulointerstitial nephritis antigen, Transforming growth factor beta-1, Bone morphogenetic protein 7, Osteopontin, Netrin-1, and Growth-regulated alpha protein as diagnostic and prognostic biomarkers in renal injuries. | 09-22-2011 |
20110306063 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE - The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using assays that detect one or more markers selected from the group consisting of Clusterin, Heart-type fatty acid binding protein, Hepatocyte growth factor, Interferon gamma, Interleukin-12 subunit beta, Interleukin-16, Interleukin-2, 72 kDa type IV collagenase, Matrix metalloproteinase-9, Midkine, and Serum amyloid P-component as diagnostic and prognostic biomarkers in renal injuries. | 12-15-2011 |
20120156701 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE - The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using assays that detect C-X-C motif chemokines-1, -2, and -3 as diagnostic and prognostic biomarker assays in renal injuries. | 06-21-2012 |
20120190044 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE - The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using a plurality of assays, one or more of which is configured to detect a kidney injury marker selected from the group consisting of metalloproteinase inhibitor 2, soluble oxidized low-density lipoprotein receptor 1, interleukin-2, von Willebrand factor, granulocyte-macrophage colony-stimulating factor, tumor necrosis factor receptor superfamily member 11B, neutrophil elastase, interleukin-1 beta, heart-type fatty acid-binding protein, beta-2-glycoprotein 1, soluble CD40 ligand, coagulation factor VII, C—C motif chemokine 2, IgM, CA 19-9, IL-10, TNF-α, and myoglobin as diagnostic and prognostic biomarkers in renal injuries. | 07-26-2012 |
20120190051 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE - Disclosed are methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, disclosed are assays that detect one or more markers selected from the group consisting of Prostatic acid phosphatase, Lactotransfenin, Soluble erythropoietin receptor, Von Willebrand factor, Soluble endothelial protein C receptor, and Beta-2-glycoprotein 1 as diagnostic and prognostic biomarkers in renal injuries. | 07-26-2012 |
20120231472 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE - The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using a one or more assays configured to detect a kidney injury marker selected from the group consisting of C—C motif chemokine 23, Transmembrane glycoprotein NMB, Brain-derived neurotrophic factor, Cathepsin S, Transforming growth factor beta-2, Urokinase-type plasminogen activator, Angiopoietin-2, Matrilysin, Carcinoembryonic antigen-related cell adhesion molecule 1, Creatine kinase MB, Insulin, Immunoglobulin M, Immunoglobulin E, Macrophage migration inhibitory factor, Galectin-3, Transforming growth factor beta-3, Heparan sulfate, soluble Cadherin-3, Complement C5, Platelet factor 4, Platelet basic protein, and Stromelysin-2 as diagnostic and prognostic biomarkers in renal injuries. | 09-13-2012 |
20120231476 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE - The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using a one or more assays configured to detect a kidney injury marker selected from the group consisting of Cathepsin B, Renin, Dipeptidyl Peptidase IV, Neprilysin, Beta-2-microglobulin, Carbonic anhydrase IX, and C-X-C motif chemokine 2 as diagnostic and prognostic biomarkers in renal injuries. | 09-13-2012 |
20120264629 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE - The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using assays that detect Beta-2-glycoprotein 1 as a diagnostic and prognostic biomarker in renal injuries. | 10-18-2012 |
20120283128 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE - The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using a plurality of assays, one or more of which is configured to detect a kidney injury marker selected from the group consisting of Hyaluronic acid, Immunoglobulin A, Immunoglobulin G1, Immunoglobulin G2, Insulin-like growth factor-binding protein 7, Alpha-1 antitrypsin, Serum amyloid P component, Metalloproteinase inhibitor 2, Hepatocyte growth factor, Intercellular adhesion molecule 1, Beta-2-glycoprotein 1, Interleukin-1 beta, Neutrophil Elastase, Tumor necrosis factor receptor superfamily member 11B, Interleukin-11, Cathepsin D, C—C motif chemokine 24, C—X—C motif chemokine 6, C—C motif chemokine 13, C—X—C motif chemokines -1, -2, and -3, Matrilysin, Interleukin-2 receptor alpha chain, Insulin-like growth factor-binding protein 3, and Macrophage colony-stimulating factor 1 as diagnostic and prognostic biomarkers in renal injuries. | 11-08-2012 |
20120315649 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE - The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using assays that detect one or more biomarkers selected from the group consisting of Tumor necrosis factor receptor superfamily member 10B, Cadherin-16, Caspase-9, Bcl2 antagonist of cell death, Caspase-1, Cadherin-1, Poly [ADP-ribose] polymerase 1, Cyclin-dependent kinase inhibitor 1, Cadherin-5, Myoglobin, Apolipoprotein A-II, Mucin-16, Carcinoembryonic antigen-related cell adhesion molecule 5, and Cellular tumor antigen p53 as diagnostic and prognostic biomarker assays in renal injuries. | 12-13-2012 |
20130005601 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE - The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using a one or more assays configured to detect a kidney injury marker selected from the group consisting of Endothelin-1, Somatotropin, and Interleukin-13 as diagnostic and prognostic biomarkers in renal injuries. | 01-03-2013 |
20130045494 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE - The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using assays that detect one or more biomarkers selected from the group consisting of Immumoglobulin A, Metalloproteinase inhibitor 4, and Thrombomodulin as diagnostic and prognostic biomarker assays in renal injuries. | 02-21-2013 |
20130157297 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE - The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using a one or more assays configured to detect a kidney injury marker selected from the group consisting of Alpha-2-HS-glycoprotein, Interleukin-9, Leukemia inhibitory factor, Macrophage colony-stimulating factor 1, Prolactin, and Stromal cell-derived factor 12 as diagnostic and prognostic biomarkers in renal injuries. | 06-20-2013 |
20130157881 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE - The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using a one or more assays configured to detect a kidney injury marker selected from the group consisting of Coagulation factor VII, CA19-9, Insulin-like growth factor-binding protein 7, C—X—C motif chemokine 6, and C—C motif chemokine 13 as diagnostic and prognostic biomarkers in renal injuries. | 06-20-2013 |
20130165344 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE - The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using a one or more assays configured to detect a kidney injury marker selected from the group consisting of Cancer antigen CA 15-3, C-C Motif chemokine 18, C-C Motif chemokine 24, Cathepsin D, C-X-C Motif chemokine 13, C-C motif chemokine 8, Interleukin-2 receptor alpha chain, Insulin-like growth factor-binding protein 3, Interleukin-11, Matrix Metalloproteinase-8, Transforming growth factor alpha, IgG1, and IgG2 as diagnostic and prognostic biomarkers in renal injuries. | 06-27-2013 |
20130203074 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE - The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using a one or more assays configured to detect a kidney injury marker selected from the group consisting of Tumor necrosis factor receptor superfamily member 8, Alpha-Fetoprotein, Thyroxine-binding globulin, Prostate-specific antigen (free form), Apolipoprotein A Apolipoprotein E, Thyrotropin subunit beta, Platelet-derived growth factor B/B dimer, C-C motif chemokine 7, C-C motif chemokine 26, Complement C4-B, Corticotropin, Interferon alpha-2, Interleukin-4 receptor alpha chain, Insulin-like growth factor-binding protein 4, Insulin-like growth factor-binding protein 5, Interleukin 21, Interleukin 23 alpha subunit, Interleukin-28A, Interleukin-33, Lutropin subunit beta, Matrix Metalloproteinase-1, Neural cell adhesion molecule 1, Pigment epithelium-derived factor, Vascular endothelial growth factor receptor 2, Vascular endothelial growth factor receptor 3, and IgG4 as diagnostic and prognostic biomarkers in renal injuries. | 08-08-2013 |
20130210029 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE IN A NON-SURGICAL ICU POPULATION - The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects admitted to a hospital critical care setting for other than a post-surgical or trauma indication. In particular, the invention relates to using assays that detect one or more markers selected from the group consisting of Insulin-like growth factor IA, soluble Epidermal growth factor receptor, and Leukocyte elastase as diagnostic and prognostic biomarkers in renal injuries. | 08-15-2013 |
20130210041 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE - The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using a plurality of assays configured to detect a kidney injury marker as diagnostic and prognostic biomarkers in renal injuries. | 08-15-2013 |
20130210043 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE - The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using a one or more assays configured to detect a kidney injury marker selected from the group consisting of Thymic stromal lymphopoietin, Vascular endothelial growth factor receptor 1, C-C motif chemokine 1, C-C motif chemokine 17, C-C motif chemokine 21, C-C motif chemokine 27, FLT-3 Ligand, Immunoglobulin G subclass 3, Interleukin-1 receptor type I, Interleukin-20, Interleukin-29, Interleukin-7, Platelet-derived growth factor A/B dimer, Platelet-derived growth factor A/A dimer, and MMP9:TIMP2 complex as diagnostic and prognostic biomarkers in renal injuries. | 08-15-2013 |
20130230871 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE - The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using a one or more assays configured to detect a kidney injury marker selected from the group consisting of Interleukin-5, Interleukin-6 receptor subunit beta, Tissue factor, Sex hormone-binding globulin, Alpha-2-macroglobulin, Apolipoprotein A-I, Calcitonin, Thrombopoietin, C-reactive protein, Intercellular adhesion molecule 3, Macrophage metalloelastase, Apolipoprotein B-100, and Fibrinogen as diagnostic and prognostic biomarkers in renal injuries. | 09-05-2013 |
20130252264 | METHODS AND COMPOSITIONS FOR THE EVALUATION OF RENAL INJURY USING HYALURONIC ACID - The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using assays that detect one or more of hyaluronic acid (HA) as diagnostic and prognostic biomarker assays in renal injuries. | 09-26-2013 |
20130316370 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE - The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using assays that detect one or more biomarkers selected from the group consisting of Beta-nerve growth factor, Interleukin-17A, Follitropin subunit beta, Collagenase 3, Follistatin, Vitamin D Binding Protein, Islet amyloid polypeptide, Insulin C-peptide, Complement Factor H, Gastric inhibitory polypeptide, Glucagon-like peptide 1, Glucagon, Involucrin, Type II cytoskeletal Keratin-1/Keratin-10, Type II cytoskeletal Keratin-6A/6B/6C, Osteocalcin, Lipopolysaccharide, Pancreatic prohormone, Peptide YY, Agouti-related protein, Ciliary neurotrophic factor, Appetite-regulating hormone, Transthyretin, Insulin receptor substrate 1, and NF-kappa-B inhibitor alpha as diagnostic and prognostic biomarker assays in renal injuries. | 11-28-2013 |
20130330752 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE - The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using a one or more assays configured to detect a kidney injury marker selected from the group consisting of Angiopoietin-related protein 3, Soluble Lymphatic vessel endothelial hyaluronic acid receptor 1, and Vascular endothelial growth factor D as diagnostic and prognostic biomarkers in renal injuries. | 12-12-2013 |
20140141528 | DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE - The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using assays that detect each of C-X-C motif chemokines-1, -2, and -3 as diagnostic and prognostic biomarker assays in renal injuries. | 05-22-2014 |
20140147864 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE - The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using a one or more assays configured to detect a kidney injury marker selected from the group consisting of Proheparin-binding EGF-like growth factor, Tenascin C, Angiopoietin-related protein 4, Fibroblast growth factor 19, Fibroblast growth factor 21, Heparin-binding growth factor 1, Angiopoietin-related protein 6, Proepiregulin, Probetacellulin, Amphiregulin, Angiogenin, Thrombospondin-2, and Collagen alpha-1 (XVIII) chain as diagnostic and prognostic biomarkers in renal injuries. | 05-29-2014 |
20140171522 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE - The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using a one or more assays configured to detect a kidney injury marker selected from the group consisting of Heat shock protein beta-1, WAP four-disulfide core domain protein 2, Choriogonadotropin subunit beta, Placenta growth factor, and Mitochondrial 60 kDa heat shock protein as diagnostic and prognostic biomarkers in renal injuries. | 06-19-2014 |
20140213477 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE - The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using a one or more assays configured to detect a kidney injury marker selected from the group consisting of Heat shock 70 kDa protein 1, Alpha-1-antitrypsin Neutrophil elastase complex, Stromelysin-1:Metalloproteinase inhibitor 2 complex, 72 kDa type IV collagenase:Metalloproteinase inhibitor 2 complex, Insulin-like growth factor 1 receptor, Myeloid differentiation primary response protein MyD88, Neuronal cell adhesion molecule, and Tumor necrosis factor ligand superfamily member 10 as diagnostic and prognostic biomarkers in renal injuries. | 07-31-2014 |
20140315752 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE - The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using a one or more assays configured to detect a kidney injury marker selected from the group consisting of Stanniocalcin-1, Antithrombin-III, Toll-like receptor 2, Triiodothyronine (T3), Thyroxine (T4), Extracellular matrix protein 1, Coagulation factor XIII A chain, Coagulation factor XIII B chain, Interleukin-17F, Interleukin-22, Vitronectin, Progesterone, Estradiol, Growth/differentiation factor 15, and Proprotein convertase subtilisin/kexin type 9 as diagnostic and prognostic biomarkers in renal injuries. | 10-23-2014 |
20140323594 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE - The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using assays that detect one or more markers selected from the group consisting of Cytoplasmic aspartate aminotransferase, soluble Tumor necrosis factor receptor superfamily member 5, soluble CD40 Ligand, soluble C-X-C Motif chemokine 16, S100-A12, Eotaxin, soluble E-selectin, Fibronectin, Granulocyte colony-stimulating factor, Granulocyte-macrophage colony-stimulating factor, Heparin-binding growth factor 2, soluble Hepatocyte growth factor receptor, Interleukin-1 receptor antagonist, Interleukin-1 beta, Interleukin-10, Interleukin-15, Interleukin-3, Myeloperoxidase, Nidogen-1, soluble Oxidized low-density lipoprotein receptor 1, Pappalysin-1, soluble P-selectin glycoprotein ligand 1, Antileukoproteinase, soluble Kit ligand, Tissue inhibitor of metalloproteinase 1, Tissue inhibitor of metalloproteinase 2, soluble Tumor necrosis factor, soluble Vascular cell adhesion molecule 1, and Vascular endothelial growth factor A as diagnostic and prognostic biomarkers in renal injuries. | 10-30-2014 |
20140363834 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE - The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using a one or more assays configured to detect a kidney injury marker selected from the group consisting of Growth/differentiation factor 2, Catalase, Vascular endothelial growth factor C, and Melanoma-derived growth regulatory protein as diagnostic and prognostic biomarkers in renal injuries. | 12-11-2014 |
20140377777 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE - The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in sepsis patients. In particular, the invention relates to using assays that detect one or more biomarkers selected from the group consisting of Insulin-like growth factor-binding protein 7, Beta-2-glycoprotein 1, Metalloproteinase inhibitor 2, Alpha-1 Antitrypsin, Leukocyte elastase, Serum Amyloid P Component, C-X-C motif chemokine 6, Immunoglobulin A, Immunoglobulin G subclass I, C-C motif chemokine 24, Neutrophil collagenase, Cathepsin D, C-X-C motif chemokine 13, Involucrin, Interleukin-6 receptor subunit beta, Hepatocyte Growth Factor, CXCL-1, -2, -3, Immunoglobulin G subclass II, Metalloproteinase inhibitor 4, C-C motif chemokine 18, Matrilysin, C-X-C motif chemokine 11, and Antileukoproteinase as diagnostic and prognostic biomarker assays of renal injury in the sepsis patient. | 12-25-2014 |
20150038595 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE - The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using a one or more assays configured to detect a kidney injury marker selected from the group consisting of Serum albumin, Protein S100-B, Glial cell line-derived neurotrophic factor, Resistin, Serum amyloid A protein, Hydrocortisone, Parathyroid hormone, and Tissue Plasminogen Activator as diagnostic and prognostic biomarkers in renal injuries. | 02-05-2015 |
20150044706 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE - The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using assays that detect Beta-2-glycoprotein 1 as a diagnostic and prognostic biomarker in renal injuries. | 02-12-2015 |
20150050674 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE - The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using a one or more assays configured to detect Chitinase-3-like protein 1 as a predictive biomarker in renal injuries. | 02-19-2015 |
20150056641 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE - The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using assays that detect Trefoil factor 3 as diagnostic and prognostic biomarker assays in renal injuries. | 02-26-2015 |
Jeffrey G. Gray, Sacramento, CA US
Patent application number | Description | Published |
---|---|---|
20090304003 | Global Virtual VPN - A method, apparatus and article of manufacture for building next generation improved global virtual private networks over the Internet. The method comprises of building two layers on top of the public infrastructure ( | 12-10-2009 |
20090304004 | Regional Virtual VPN - A method, apparatus and article of manufacture for building next generation improved regional virtual private networks over the Internet. The method comprises of building two layers on top of the public infrastructure ( | 12-10-2009 |
Jeremy Gray, San Francisco, CA US
Patent application number | Description | Published |
---|---|---|
20110117637 | ZERO-MODE WAVEGUIDES WITH NON-REFLECTING WALLS - The application relates to improved optical containment structures, methods of manufacture and use, and systems for employing same. The optical containment structures generally comprise zero-mode waveguide structures having non-reflective walls. The non-reflective walls allow the preparation of optical containment regions in which the optical containment dimensions can be decoupled from the solution containment dimensions. The application also relates to methods for producing islands of functionality within nanoscale apertures. | 05-19-2011 |
20110210094 | METHODS FOR PRODUCING ZMWS WITH ISLANDS OF FUNCTIONALITY - The application relates to methods for producing islands of functionality within nanoscale apertures. Islands of functionality can be produced by growing an aperture constriction layer from the walls, functionalizing the exposed base of the aperture, then removing the aperture constriction layer. The aperture constriction layer can be produced, for example, by anodically growing an oxide layer onto a cladding through which the aperture extends. The islands of functionality can be used to bind a single molecule of interest, such as an enzyme within the nanoscale aperture. | 09-01-2011 |
20120322692 | LOADING MOLECULES ONTO SUBSTRATES - Disclosed are compositions, devices, and methods for loading molecules of interest onto a substrate by contacting beads having molecules of interest attached to them with the substrate, for example by providing a field that brings the beads into proximity or contact with the substrate and moves the beads with respect to the substrate. Such molecules of interest can be deposited onto substrates for single-molecule analysis. | 12-20-2012 |
20130296195 | Selectively Functionalized Arrays - Methods, substrates, and devices related to arrays of optical confinements having surfaces with high levels of bias. Substrates having transparent or silica based portions and opaque or reflective portions are treated with 1) a selective passivating agent, that selectively coats the opaque or reflective regions, 2) a functionalizing agent such as a coupling agent, and 3) a selective removal agent, which selectively removes functionalizing agent from the passivated opaque or reflective surfaces. | 11-07-2013 |
Jim Gray, Albany, CA US
Patent application number | Description | Published |
---|---|---|
20090094528 | USER INTERFACES AND UPLOADING OF USAGE INFORMATION - A graphical user interface (GUI) can be used to provide information reflecting a user's interaction with a product using a stand-alone portable device. The user can respond to questions while interacting with the product. The responses are logged by the portable device and subsequently uploaded to the computer system, which forwards them via the Internet to a server. The computer system also forwards registration information to the server. The registration information identifies the user and the product. Based on information received from the server, the computer system generates a GUI that includes a report summarizing the information forwarded from the computer system, including the name of the product the user was interacting with, and that also includes names of additional products selected based on the forwarded information. | 04-09-2009 |
20090094540 | METHODS AND SYSTEMS THAT MONITOR LEARNING PROGRESS - A graphical user interface (GUI) can be used to provide information reflecting a user's interaction with a product using a stand-alone portable device. The portable device, operable as a stand-alone device, logs inputs by a user who is interacting with a product using the portable device. Information from the portable device, including the inputs, is uploaded and then forwarded to a server. Registration information identifying the user and the product can also be sent to the server. A report specific to the user and summarizing the information forwarded to the server can be displayed, including the name of the product the user was interacting with, along with the names of additional products selected based on the forwarded information. | 04-09-2009 |
John Gray, Woodland Hills, CA US
Patent application number | Description | Published |
---|---|---|
20100232992 | ACTUATOR WITH GROOVED PISTON FOR A FLUID INFUSION DEVICE - An apparatus for delivering a fluid includes a housing, an inlet in the housing for receiving the fluid, and an outlet in the housing for discharging the fluid. A piston channel is provided within the housing through which the fluid flows from the inlet to the outlet. An actuator is positioned within the housing and is moveable between a retracted position and a forward position, the actuator defining a piston chamber for storing fluid received through the inlet when the actuator is in the retracted position and for driving the fluid stored in the piston chamber toward the outlet when the actuator transitions from the retracted position to the forward position. The actuator includes an armature and a piston coupled to the armature and moveable within the piston channel. The piston is provided with a groove in an outer surface for conducting fluid from the inlet to the outlet. | 09-16-2010 |
20120248151 | ACTUATOR WITH GROOVED PISTON FOR A FLUID INFUSION DEVICE - An apparatus for delivering a fluid includes a housing, an inlet in the housing for receiving the fluid, and an outlet in the housing for discharging the fluid. A piston channel is provided within the housing through which the fluid flows from the inlet to the outlet. An actuator is positioned within the housing and is moveable between a retracted position and a forward position, the actuator defining a piston chamber for storing fluid received through the inlet when the actuator is in the retracted position and for driving the fluid stored in the piston chamber toward the outlet when the actuator transitions from the retracted position to the forward position. The actuator includes an armature and a piston coupled to the armature and moveable within the piston channel. The piston is provided with a groove in an outer surface for conducting fluid from the inlet to the outlet. | 10-04-2012 |
20140100527 | INFUSION DEVICE WITH A GROOVED PISTON CHANNEL WALL - An apparatus for delivering a fluid includes a housing, an inlet in the housing for receiving the fluid, and an outlet in the housing for discharging the fluid. A piston channel is provided within the housing through which the fluid flows from the inlet to the outlet. An actuator is positioned within the housing and is moveable between a retracted position and a forward position, the actuator defining a piston chamber for storing fluid received through the inlet when the actuator is in the retracted position and for driving the fluid stored in the piston chamber toward the outlet when the actuator transitions from the retracted position to the forward position. The actuator includes an armature and a piston coupled to the armature and moveable within the piston channel. The piston channel wall is provided with a groove for conducting fluid from the inlet to the outlet. | 04-10-2014 |
Jonathan D. Gray, Long Beach, CA US
Patent application number | Description | Published |
---|---|---|
20110080897 | Communications resource management - A communications resource management system. The system includes a first module for prioritizing incoming messages and a second module for steering the messages in response to the prioritization by the first module. The first module assigns a message priority to each message based on a plurality of parameters such as mission mode, message type, and timeliness factor. The second module selects the most optimal communications resource for the message with the highest message priority by assigning a transmitter priority to each communications resource based on a plurality of factors such as estimated message arrival time, availability, and waveform compatibility. The message with the highest message priority is steered to the communications resource with the highest transmitter priority at the moment the message is sent. The first and second modules are each implemented using decision tree logic. | 04-07-2011 |
Kevin Gray, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20100021988 | PECTATE LYASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM - The invention is directed to polypeptides having pectate lyase (pectinase) activity, polynucleotides encoding the polypeptides, and methods for making and using these polynucleotides and polypeptides. The polypeptides of the invention can be used as pectate lyases to catalyze the beta-elimination or hydrolysis of pectin and/or polygalacturonic acid, such as 1,4-linked alpha-D-galacturonic acid. The invention provides methods of treating fibers, fabrics or any pectate- or polygalacturonic acid-comprising material using one or more pectate lyases of the invention. | 01-28-2010 |
20110016545 | Xylanases, Nucleic Acids Encoding Them and Methods For Making and Using Them - The invention relates to enzymes having xylanase, mannanase and/or glucanase activity, e.g., catalyzing hydrolysis of internal β-1,4-xylosidic linkages or endo-β-1,4-glucanase linkages; and/or degrading a linear polysaccharide beta-1,4-xylan into xylose. Thus, the invention provides methods and processes for breaking down hemicellulose, which is a major component of the cell wall of plants, including methods and processes for hydrolyzing hemicelluloses in any plant or wood or wood product, wood waste, paper pulp, paper product or paper waste or byproduct. In addition, methods of designing new xylanases, mannanases and/or glucanases and methods of use thereof are also provided. The xylanases, mannanases and/or glucanases have increased activity and stability at increased pH and temperature. | 01-20-2011 |
20120237981 | AMYLASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM - In one aspect, the invention is directed to polypeptides having an amylase activity, polynucleotides encoding the polypeptides, and methods for making and using these polynucleotides and polypeptides. In one aspect, the polypeptides of the invention can be used as amylases, for example, alpha amylases, to catalyze the hydrolysis of starch into sugars. In one aspect, the invention provides delayed release compositions comprising a desired ingredient coated by a latex polymer coating. | 09-20-2012 |
Kevin A. Gray, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20090062139 | PHYTASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM - The invention provides isolated and recombinant phytase enzymes. In one aspect, the phytases are produced by modification of the wild type appA of | 03-05-2009 |
20090220480 | CELLULOLYTIC ENZYMES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM - The invention provides polypeptides having any cellulolytic activity, e.g., a cellulase activity, a endoglucanase, a cellobiohydrolase, a beta-glucosidase, a xylanase, a mannanse, a β-xylosidase, an arabinofuranosidase, and/or an oligomerase activity, polynucleotides encoding these polypeptides, and methods of making and using these polynucleotides and polypeptides. In one aspect, the invention is directed to polypeptides having any cellulolytic activity, e.g., a cellulase activity, e.g., endoglucanase, cellobiohydrolase, beta-glucosidase, xylanase, mannanse, β-xylosidase, arabinofuranosidase, and/or oligomerase activity, including thermostable and thermotolerant activity, and polynucleotides encoding these enzymes, and making and using these polynucleotides and polypeptides. In one aspect, the invention provides polypeptides having an oligomerase activity, e.g., enzymes that convert recalcitrant soluble oligomers to fermentable sugars in the saccharification of biomass. The polypeptides of the invention can be used in a variety of pharmaceutical, agricultural, food and feed processing and industrial contexts. The invention also provides compositions or products of manufacture comprising mixtures of enzymes comprising at least one enzyme of this invention. | 09-03-2009 |
20100047392 | Enzymes Having Alpha Amylase Activity and Methods of Making and Using Them - The invention relates to alpha amylases and to polynucleotides and polypeptides encoding the alpha amylases. In addition, methods of using the alpha amylases are also provided. The alpha amylases have increased activity and stability at acidic, neutral and alkaline pH and at increased temperatures. | 02-25-2010 |
20100112666 | Dehalogenases, Nucleic Acids Encoding Them and Methods for Making and Using Them - The invention relates to haloalkane dehalogenases and to polynucleotides encoding the haloalkane dehalogenases. In addition methods of designing new dehalogenases and method of use thereof are also provided. The dehalogenases have increased activity and stability at increased pH and temperature. | 05-06-2010 |
20100221779 | PHYTASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM - The invention provides isolated and recombinant phytase enzymes. In one aspect, the phytases are produced by modification of the wild type appA of | 09-02-2010 |
20100267110 | LACCASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM - The invention provides laccases, polynucleotides encoding these enzymes, the methods of making and using these polynucleotides and polypeptides. | 10-21-2010 |
20110076740 | Amylases, Nucleic Acids Encoding Them and Methods for Making and Using Them - In one aspect, the invention is directed to polypeptides having an amylase activity, polynucleotides encoding the polypeptides, and methods for making and using these polynucleotides and polypeptides. The polypeptides of the invention can be used as amylases to catalyze the hydrolysis of starch into sugars. | 03-31-2011 |
20110171693 | AMYLASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM - In one aspect, the invention is directed to polypeptides having an amylase activity, polynucleotides encoding the polypeptides, and methods for making and using these polynucleotides and polypeptides. In one aspect, the polypeptides of the invention can be used as amylases, for example, alpha amylases, to catalyze the hydrolysis of starch into sugars. In one aspect, the invention provides delayed release compositions comprising an desired ingredient coated by a latex polymer coating. | 07-14-2011 |
20120040412 | AMYLASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM - In one aspect, the invention is directed to polypeptides having an amylase activity, polynucleotides encoding the polypeptides, and methods for making and using these polynucleotides and polypeptides. The polypeptides of the invention can be used as amylases to catalyze the hydrolysis of starch into sugars. | 02-16-2012 |
20120266328 | CELLULOYTIC ENZYMES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM - The invention is directed to polypeptides having any cellulolytic activity, e.g., a cellulase activity, e.g., endoglucanase, cellobiohydrolase, beta-glucosidase, xylanase, mannanse, β-xylosidase, arabinofuranosidase, and/or oligomerase activity, including thermostable and thermotolerant activity, and polynucleotides encoding these enzymes, and making and using these polynucleotides and polypeptides. The polypeptides of the invention can be used in a variety of pharmaceutical, agricultural, food and feed processing and industrial contexts. The invention also provides compositions or products of manufacture comprising mixtures of enzymes comprising at least one enzyme of this invention. | 10-18-2012 |
20130115675 | Dehalogenases, Nucleic Acids Encoding Them and Methods for Making and Using Them - The invention relates to haloalkane dehalogenases and to polynucleotides encoding the haloalkane dehalogenases. In addition methods of designing new dehalogenases and method of use thereof are also provided. The dehalogenases have increased activity and stability at increased pH and temperature. | 05-09-2013 |
20130224800 | Enzymes Having Alpha Amylase Activity and Methods of Making and Using them - The invention relates to alpha amylases and to polynucleotides encoding the alpha amylases. In addition methods of designing new alpha amylases and methods of use thereof are also provided. The alpha amylases have increased activity and stability at acidic, neutral and alkaline pH and increased temperature. | 08-29-2013 |
20130227741 | CELLULOYTIC ENZYMES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM - The invention is directed to polypeptides having any cellulolytic activity, e.g., a cellulase activity, e.g., endoglucanase, cellobiohydrolase, beta-glucosidase, xylanase, mannanse, β-xylosidase, arabinofuranosidase, and/or oligomerase activity, including thermostable and thermotolerant activity, and polynucleotides encoding these enzymes, and making and using these polynucleotides and polypeptides. The polypeptides of the invention can be used in a variety of pharmaceutical, agricultural, food and feed processing and industrial contexts. The invention also provides compositions or products of manufacture comprising mixtures of enzymes comprising at least one enzyme of this invention. | 08-29-2013 |
20130344544 | Amylases, Nucleic Acids Encoding Them and Methods for Making and Using Them - In one aspect, the invention is directed to polypeptides having an amylase activity, polynucleotides encoding the polypeptides, and methods for making and using these polynucleotides and polypeptides. The polypeptides of the invention can be used as amylases to catalyze the hydrolysis of starch into sugars. | 12-26-2013 |
20140298499 | Xylanases, Nucleic Acids Encoding Them and Methods for Making and Using Them - The invention relates to enzymes having xylanase, mannanase and/or glucanase activity, e.g., catalyzing hydrolysis of internal β-1,4-xylosidic linkages or endo-β-1,4-glucanase linkages; and/or degrading a linear polysaccharide beta-1,4-xylan into xylose. Thus, the invention provides methods and processes for breaking down hemicellulose, which is a major component of the cell wall of plants, including methods and processes for hydrolyzing hemicelluloses in any plant or wood or wood product, wood waste, paper pulp, paper product or paper waste or byproduct. In addition, methods of designing new xylanases, mannanases and/or glucanases and methods of use thereof are also provided. The xylanases, mannanases and/or glucanases have increased activity and stability at increased pH and temperature. | 10-02-2014 |
Malcolm Gray, Sunnyvale, CA US
Patent application number | Description | Published |
---|---|---|
20120162460 | GLOBAL ARMING METHOD FOR IMAGE PROCESSING PIPELINE - Each unit among a pipeline of image processing units receives a new configuration vector (update), and the received new vector is only applied in sync with the Timing-derived trigger signal within a hardware-enabled time period. A hardware enable signal is logically combined with a Timing-derived triggering event signal to control a switch that applies the new received vector to the processing unit. This ensures that each image processing unit (stage) in the chain of image processing units is updated in sequence even if the CPU has output the updated configuration vectors independently of the Timing of the Data and without regard for the delay through each of the processing units. The Timing-derived triggering event is used to synchronize the application of a received configuration vector update with the receipt by the unit of a new frame of image DATA. | 06-28-2012 |
Michael Hunter Gray, Los Angeles, CA US
Patent application number | Description | Published |
---|---|---|
20120296705 | Method and System for Managing Network Marketing - The present inventive subject matter is a method that can receive sales activity data from a plurality of users, calculate metrics based on the sales activity data, the metrics having an indicator that a first user's sales numbers are greater than fifty percent of a predetermined goal followed by a the ability to generate a message to be sent to a second user with the message configured to inform the second user regarding the progress of the first user's sales activities; the message incorporates a link that is selected by the second user to send a message back to the first user. | 11-22-2012 |
20130290058 | APPOINTMENT NEGOTIATION SYSTEMS AND METHODS - A server for providing scheduling services to at least two remote devices includes a communications interface for transmitting scheduling options to the at least two remote devices and receiving user inputs from the at least two remote devices. The server further includes a processing circuit configured to manage scheduling services for the at least two remote devices. In one embodiment, the server provides scheduling services for two users, allowing the two users to schedule an appointment with each other. In another embodiment, the server provides scheduling services for a first user and a plurality of second users, allowing the multiple users to schedule an appointment with one another. | 10-31-2013 |
Michael R. Gray, Foster City, CA US
Patent application number | Description | Published |
---|---|---|
20080215672 | System, Method, and Computer Program Product for a Scalable, Configurable, Client/Server, Cross-Platform Browser for Mobile Devices - Described herein are systems, methods, computer program products, and combinations and sub-combinations thereof, for enabling web content (as well as other objects) to be loaded on mobile devices (as well as other types of devices), and for users of mobile devices to operate with such web content on their mobile devices in an interactive manner while in an off-line mode. | 09-04-2008 |
20100174679 | Method, System, and Computer Program Product for Synchronization of Similar Data Objects With Event Information - A computer-implemented method for receiving information at a first device is provided. The method includes storing a first data object on the first device in a first device-specific representation, receiving a batch of information in response to the first device transitioning from an off-line state to an online state, processing the modification event to recover the modification, updating the first data object based on the recovered modification, and transmitting an acknowledgement indicating that the modification event was successfully processed by the first device. The batch of information includes a modification event. The content of the batch was determined based at least on a state of data stored on the first device. The modification event was generated based on at least a modification made to a second data object stored at a second device in a second device-specific representation. | 07-08-2010 |
20120226735 | Method, System, and Computer Program Product for Synchronization of Similar Data Objects with Event Information - A computer-implemented method for updating an object on a mobile device is provided. The computer-implemented method includes maintaining at a server a plurality of channels, the plurality of channels including at least a first representation of the object, generating a modification event when a change to the object is detected, responsive to the modification event, at least updating the representation of the object yielding a second representation of the object, and conveying, during a synchronization process, the second representation of the object to the mobile device. | 09-06-2012 |
20140237065 | System, Method, and Computer Program Product for Server Side Processing in a Mobile Device Environment - Described herein are systems, methods, computer program products, and combinations and sub-combinations thereof, for enabling web content (as well as other objects) to be loaded on mobile devices (as well as other types of devices), and for users of mobile devices to operate with such web content on their mobile devices in an interactive manner while in an off-line mode. | 08-21-2014 |
Michael Scott Gray, Encinitas, CA US
Patent application number | Description | Published |
---|---|---|
20110181927 | Systems And Methods For Detecting Media Edges In An Automatic Document Feeder - Systems and methods are disclosed for detecting media edges in an automatic document feeder including a scan backing strip that is colored to contrast with the color of a medium being fed through the automatic feeder. Logic instructions are included that cause a computer processor to detect when the medium is being fed through the automatic document feeder based on the difference in color between the scan backing strip and the medium. | 07-28-2011 |
Nathanael S. Gray, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20080214541 | COMPOSITIONS AND METHODS FOR INDUCING OSTEOGENESIS - The present invention provides compositions and methods for differentiating and transdifferentiating mammalian cells into cells of an osteoblast lineage. | 09-04-2008 |
20090036423 | IMMUNOSUPPRESANT COMPOUNDS AND COMPOSITIONS - The present invention relates to immunosuppressant, process for their production, their uses and pharmaceutical compositions containing them. The invention provides a novel class of compounds useful in the treatment or prevention of diseases or disorders mediated by lymphocyte interactions, particularly diseases associated with EDG receptor mediated signal transduction. | 02-05-2009 |
20110092491 | Compounds and Compositions as Inhibitors of Receptor Tyrosine Kinase Activity - The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with cSRC, Lck, FGFR3, Flt3, TrkB, Bmx, and/or PFGFRα kinase activity. | 04-21-2011 |
Nathanael Schiander Gray, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20090105250 | COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS - The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of the Abl, Bcr-Abl, FGFR3, PDGFRβ and b-Raf kinases. | 04-23-2009 |
Pearl Gray, Los Angeles, CA US
Patent application number | Description | Published |
---|---|---|
20110274708 | SHORT-FORM HUMAN MD-2 AS A NEGATIVE REGULATOR OF TOLL-LIKE RECEPTOR 4 SIGNALING - The present invention is based on a novel, alternatively spliced human isoform of MD-2 (MD-2s). In addition, the present invention relates to modified MD-2 proteins, wherein one or more tyrosine residues have been mutated to phenylalanine. In various embodiments, the invention relates to methods and kits for preventing, reducing the likelihood of developing and/or treating various conditions using MD-2s. The invention also describes methods of determining the risk of a subject to various conditions. | 11-10-2011 |
Peter C. Gray, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20100135904 | COMPOSITIONS AND METHODS FOR THE INHIBITION OF CRIPTO / GRP78 COMPLEX FORMATION AND SIGNALING - The present invention provides methods compositions and methods for treating a hyperproliferative disease comprising disrupting Cripto/GRP78 complex formation in a hyperproliferative cell. In certain embodiments, an antibody and/or siRNA may be used to inhibit Cripto/GRP78 binding, optionally coupled with other cancer therapies. Also provided are methods for identifying therapeutic compounds which can selectively inhibit Cripto/GRP78 binding. | 06-03-2010 |
20110009319 | CRIPTO ANTAGONISM OF ACTIVIN AND TGF-B SIGNALING - Cripto, a developmental oncoprotein, antagonizes activin and TGF-b signaling by forming a complex with activin and TGF-b and their type II receptors. This complex precludes the formation of a functional activin/TGF-b•type II•type I complex, thereby blocking the signaling of activin and TGF-b. Cripto may be generally capable of blocking antiproliferative Smad2/3 signals and provides a novel mechanism of oncogenic action with multiple therapeutic implications. Inhibiting the formation of Cripto and activin/TGF-b complex may enhance antiproliferative effects of activin and TGF-b. | 01-13-2011 |
20120088287 | CRIPTO ANTAGONISM OF ACTIVIN AND TGF-B SIGNALING - Cripto, a developmental oncoprotein, antagonizes activin and TGF-b signaling by forming a complex with activin and TGF-b and their type II receptors. This complex precludes the formation of a functional activin/TGF-b•type II•type I complex, thereby blocking the signaling of activin and TGF-b. Cripto may be generally capable of blocking antiproliferative Smad2/3 signals and provides a novel mechanism of oncogenic action with multiple therapeutic implications. Inhibiting the formation of Cripto and activin/TGF-b complex may enhance antiproliferative effects of activin and TGF-b. | 04-12-2012 |
20120141469 | CRIPTO ANTAGONISM OF ACTIVIN AND TGF-B SIGNALING - Cripto, a developmental oncoprotein, antagonizes activin and TGF-b signaling by forming a complex with activin and TGF-b and their type II receptors. This complex precludes the formation of a functional activin/TGF-b•type II•type I complex, thereby blocking the signaling of activin and TGF-b. Cripto may be generally capable of blocking antiproliferative Smad2/3 signals and provides a novel mechanism of oncogenic action with multiple therapeutic implications. Inhibiting the formation of Cripto and activin/TGF-b complex may enhance antiproliferative effects of activin and TGF-b. | 06-07-2012 |
Philippa E.k. Gray, Sunnyvale, CA US
Patent application number | Description | Published |
---|---|---|
20110264144 | LUMBAR-SACRAL STRUT - Medical devices for the treatment of spinal conditions are described herein. The medical device includes a main body that is adapted to be placed between the L5 vertebra and the sacrum so that the main body acts as a spacer with respect to the L5 vertebra and the sacrum to maintain distraction therebetween when the spine moves to extension. | 10-27-2011 |
Phillip Neal Gray, Carlsbad, CA US
Patent application number | Description | Published |
---|---|---|
20090099042 | Reverse Two-Hybrid System for Identification of Interaction Domains - The present invention provides methods for producing allele libraries and vectors for producing these libraries. The present invention also provides methods of identifying interaction domains between proteins. The vectors, kits, and methods of the present invention suitably utilize recombinational cloning to efficiently generate and screen full-length mutant alleles of target sequences of interest. | 04-16-2009 |
Richard J. Gray, Emerald Hills, CA US
Patent application number | Description | Published |
---|---|---|
20080288303 | Method for Detecting and Preventing Fraudulent Internet Advertising Activity - A method for preventing fraud in Internet-based advertising. The first step of this method is providing behavior-tracking software on a user computer. That software tracks and analyzes the user's activity across multiple content providers. Next, the system displays content, including advertising, based on preferences inferred from previous activity. Finally, the system identifies behavior patterns consistent with fraudulent activity. | 11-20-2008 |
Richard J. Gray, Carmel Valley, CA US
Patent application number | Description | Published |
---|---|---|
20100310629 | INTRAPERICARDIAL ANTIARRHYTHMIC DELIVERY - Certain embodiments provide a method, of treating or reducing a risk of postoperative cardiac arrhythmia, including: creating an opening in a mammal's body; advancing a releasing member from outside the body, through the opening, and toward the mammal's heart; positioning the releasing member between a visceral layer and a parietal layer of pericardium of the mammal's heart; and at least partially closing the opening in the body, leaving the releasing member in the pericardial space. In certain embodiments, the releasing member releases an antiarrhythmic drug into the mammal's pericardial space and is configured not to impede significantly a systolic or a diastolic function of the heart while the releasing member resides in the pericardial space. | 12-09-2010 |
Robert Louis Gray, Sacramento, CA US
Patent application number | Description | Published |
---|---|---|
20080307599 | MULTI-PURPOSE SQUEEGEE AND CUTTING TOOL - The present invention discloses a multi-purpose squeegee and cutting tool for use by the human hand. The tool meets the continuing need to be able to apply adhesive films to smooth surfaces without capturing air bubbles, creases in the film or adhesive lumps between the film and the surface. There have been a number of tools used and patented to accomplish this task. The disclosed invention is a new and novel multi-purpose tool that can be used to remove creases in the film, bubbles and lumps while having a built-in knife for piercing bubbles, cutting and trimming the adhesive film. | 12-18-2008 |
Robert P. Gray, Salinas, CA US
Patent application number | Description | Published |
---|---|---|
20100316773 | Hollow-Celery Stick and Celery Pack | 12-16-2010 |
20120244259 | CELERY PACK - A sanitized, ready-to-use and ready-to-eat celery pack is disclosed wherein the package consists of limbs that are from 6- to 18-inches in length and weigh from 0.10 to 11.75 pounds. The limbs are prepared by removing the butt, heart and leaves from celery stalks, cut to lengths from 6 to 18-inches, sorted by length, sanitized and packaged. | 09-27-2012 |
Stephen Gray, Glendora, CA US
Patent application number | Description | Published |
---|---|---|
20120129618 | INFLATABLE SEALED AIR SUPPORT DEVICE - A sealed air support structure including at least one sealed air chamber. The at least one sealed air chamber includes at least a first side support and a second side support, each having a support end and a base end. The at least one sealed air chamber includes a main beam with a first end coupled with the support end of the first side support and a second end coupled with the support end of the second side support. A first plurality of connectors coupled with the base end of the first side support and a second plurality of connectors coupled with the base end of the second side support are configured to detachably couple with a plurality of connectors disposed on a cold-air inflatable structure. The at least one sealed air chamber is configured to support a weight applied to the main beam. | 05-24-2012 |
Stephen J. Gray, Redondo Beach, CA US
Patent application number | Description | Published |
---|---|---|
20080267350 | Integrated carry-on baggage cart and passenger screening station - The present invention is directed toward an integrated security checkpoint that can screen both individual passengers and carry-on carts containing their baggage. The methods, apparatuses, and systems of the present invention enable the efficient scanning of both individual passengers and their respective carry-on carts in the same secure area by providing individual passengers with a novel screening cart, permitting passengers to send the screening cart through an X-ray imaging machine, and permitting passengers to walk through an adjacent metal detector where, once cleared, the individual passenger can retrieve his or her screening cart. | 10-30-2008 |
20090041186 | Integrated Carry-on Baggage Cart and Passenger Screening Station - The present invention is directed towards apparatuses and methods for securing a location. Particularly, the present invention is directed towards methods, apparatuses, and integrated systems for the screening of individual passengers and their corresponding carry-on baggage carts with improved throughput, efficiency, and quality. In addition, the current invention is directed towards a carry-on baggage cart specifically designed for the disclosed integrated carry-on baggage cart and passenger screening system of the present invention. | 02-12-2009 |
20100158191 | Integrated Carry-On Baggage Cart and Passenger Screening Station - The present invention is directed towards apparatuses and methods for securing a location. Particularly, the present invention is directed towards methods, apparatuses, and integrated systems for the screening of individual passengers and their corresponding carry-on baggage carts with improved throughput, efficiency, and quality. In addition, the current invention is directed towards a carry-on baggage cart specifically designed for the disclosed integrated carry-on baggage cart and passenger screening system of the present invention. | 06-24-2010 |
Steven John Gray, Coronado, CA US
Patent application number | Description | Published |
---|---|---|
20120234340 | KIT CONTAINING MATERIALS AND INFORMATION FOR INDIVIDUALIZED COLORIZING - A system and method for formulation of a personalized permanent hair color product. The system and method are used to produce on-site at the salon or home, a permanent, semi permanent and/or stained hair color custom mixed to according to features and individual parameters for each person, based upon an assessment test completed by the individual or a professional, based upon the person's “map” and characteristics. The person is then able to choose the quadrant of color (i.e. light blonde, blonde, red, brown, dark brown), and receive a unique color based upon his or her own “colormap”. Colormapping cannot only determine what colors work best with an individual's features, but also how best to structure it. | 09-20-2012 |
Thomas A. Gray, Santa Rose, CA US
Patent application number | Description | Published |
---|---|---|
20090247098 | System and Method for Autoranging in Test Apparatus - A system for receiving signals and performing autoranging is disclosed. The system includes an adjustable attenuator at an input. A mixer combines the input signal with a tuning frequency to generate a mixed signal. The mixed signal is filtered to generate a component of the input signal at the tuning frequency. A signal detector detects the signal level of the input signal and the adjustable attenuator is adjusted in response to the signal level. | 10-01-2009 |
Timothy M. Gray, San Dimas, CA US
Patent application number | Description | Published |
---|---|---|
20100232144 | Under Cabinet Light Fixture - An under cabinet light fixture has a housing with outer surface portions thereof adapted to be positioned closely adjacent, spaced-apart from, and substantially parallel to a substantially planar support surface. The housing has a bottom access panel pivotally connected to it, with first and second panel portions so that the bottom access panel pivots between a closed operating condition and an open access condition. A reflector and lamp sockets are connected to the housing and the reflector is positioned to reflect and radiate light toward and through the second panel portion of the bottom access panel to provide enhanced visibility of light radiating from the support surface when the light fixture is in the operating position. | 09-16-2010 |
Wayne Gray, Sunnyvale, CA US
Patent application number | Description | Published |
---|---|---|
20120036367 | Systems and Methods for Transparent Configuration Authentication of Networked Devices - Methods and systems are disclosed for providing secure transmissions across a network comprising a transmitting device and a receiving device. At the transmitting device, a stream of watermark bits is generated. Next, a plurality of watermarks is generated, each of the plurality of watermarks comprising an index number and a portion of the stream of watermark bits. The watermarks are inserted into each header of a plurality of outgoing packets. At the receiving device, the plurality of outgoing packets are received and it is determined if a received packet is valid based on the watermark in the header of the received packet. The stream of watermark bits may be generated using a stream cipher such as RC4, a block cipher such as 3DES in CBC mode, or other equivalent pseudo-random stream generating techniques. | 02-09-2012 |
20130311782 | Packet Validation Using Watermarks - Methods and systems are disclosed for providing secure transmissions across a network comprising a transmitting device and a receiving device. At the transmitting device, a stream of watermark bits is generated. Next, a plurality of watermarks is generated, each of the plurality of watermarks comprising an index number and a portion of the stream of watermark hits. The watermarks are inserted, into each header of a plurality of outgoing packets. At the receiving device, the plurality of outgoing packets are received and it is determined if a received packet is valid based on the watermark in the header of the received packet. The stream of watermark bits may be generated using a stream cipher such as RC4, a block cipher such as 3DES in CBC mode, or other equivalent pseudo-random stream generating techniques. | 11-21-2013 |